{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:09:12Z","timestamp":1776406152081,"version":"3.51.2"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hospital da Luz SA"},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["RNEM-LISBOA-01-0145-FEDER-022125"],"award-info":[{"award-number":["RNEM-LISBOA-01-0145-FEDER-022125"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/QUI\/00100\/2020 PTDC\/QUI-QAN\/32242\/2017"],"award-info":[{"award-number":["UID\/QUI\/00100\/2020 PTDC\/QUI-QAN\/32242\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sulfotransferase enzymes (SULT) catalyse sulfoconjugation of drugs, as well as endogenous mediators, gut microbiota metabolites and environmental xenobiotics. To address the limited evidence on sulfonation activity from clinical research, we developed a clinical metabolic phenotyping method using paracetamol as a probe substrate. Our aim was to estimate sulfonation capability of phenolic compounds and study its intraindividual variability in man. A total of 36 healthy adult volunteers (12 men, 12 women and 12 women on oral contraceptives) received paracetamol in a 1\u00a0g-tablet formulation on three separate occasions. Paracetamol and its metabolites were measured in plasma and spot urine samples using liquid chromatography-high resolution mass spectrometry. A metabolic ratio (Paracetamol Sulfonation Index\u2014PSI) was used to estimate phenol SULT activity. PSI showed low intraindividual variability, with a good correlation between values in plasma and spot urine samples. Urinary PSI was independent of factors not related to SULT activity, such as urine pH or eGFR. Gender and oral contraceptive intake had no impact on PSI. Our SULT phenotyping method is a simple non-invasive procedure requiring urine spot samples, using the safe and convenient drug paracetamol as a probe substrate, and with low intraindividual coefficient of variation. Although it will not give us mechanistic information, it will provide us an empirical measure of an individual\u2019s sulfonator status. To the best of our knowledge, our method provides the first standardised in vivo empirical measure of an individual\u2019s phenol sulfonation capability and of its intraindividual variability. EUDRA-CT 2016-001395-29, NCT03182595 June 9, 2017.<\/jats:p>","DOI":"10.1038\/s41598-021-88393-3","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T10:13:30Z","timestamp":1619518410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A simple method to measure sulfonation in man using paracetamol as probe drug"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2898-0816","authenticated-orcid":false,"given":"Nat\u00e1lia","family":"Marto","sequence":"first","affiliation":[]},{"given":"Judit","family":"Morello","sequence":"additional","affiliation":[]},{"given":"Alexandra M. M.","family":"Antunes","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Azeredo","sequence":"additional","affiliation":[]},{"given":"Em\u00edlia C.","family":"Monteiro","sequence":"additional","affiliation":[]},{"given":"Sofia A.","family":"Pereira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"88393_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3109\/03602532.2012.748794","volume":"45","author":"M Runge-Morris","year":"2013","unstructured":"Runge-Morris, M., Kocarek, T. A. & Falany, C. N. Regulation of the cytosolic sulfotransferases by nuclear receptors. Drug Metab. Rev. 45, 15\u201333. https:\/\/doi.org\/10.3109\/03602532.2012.748794 (2013).","journal-title":"Drug Metab. Rev."},{"key":"88393_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cbi.2016.05.005","volume":"259","author":"MWH Coughtrie","year":"2016","unstructured":"Coughtrie, M. W. H. Function and organization of the human cytosolic sulfotransferase (SULT) family. Chem. Biol. Interact. 259, 2\u20137. https:\/\/doi.org\/10.1016\/j.cbi.2016.05.005 (2016).","journal-title":"Chem. Biol. Interact."},{"key":"88393_CR3","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1126\/science.1223813","volume":"336","author":"JK Nicholson","year":"2012","unstructured":"Nicholson, J. K. et al. Host-gut microbiota metabolic interactions. Science (80) 336, 1262\u20131267. https:\/\/doi.org\/10.1126\/science.1223813 (2012).","journal-title":"Science (80)"},{"key":"88393_CR4","doi-asserted-by":"publisher","first-page":"34494","DOI":"10.1074\/jbc.M113.510974","volume":"288","author":"I Cook","year":"2013","unstructured":"Cook, I., Wang, T., Falany, C. N. & Leyh, T. S. High accuracy in silico sulfotransferase models. J. Biol. Chem. 288, 34494\u201334501. https:\/\/doi.org\/10.1074\/jbc.M113.510974 (2013).","journal-title":"J. Biol. Chem."},{"key":"88393_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jphs.2015.06.004","volume":"128","author":"Y Hui","year":"2015","unstructured":"Hui, Y. et al. Sulfation of afimoxifene, endoxifen, raloxifene, and fulvestrant by the human cytosolic sulfotransferases (SULTs): A systematic analysis. J. Pharmacol. Sci. 128, 144\u2013149. https:\/\/doi.org\/10.1016\/j.jphs.2015.06.004 (2015).","journal-title":"J. Pharmacol. Sci."},{"key":"88393_CR6","unstructured":"Niehues, M., Varoglu, M., Nguyen, L., et al. Human Sulfotransferase ( SULT ) Reaction Phenotyping of Tedizolid. ECCMID (2015)."},{"key":"88393_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/toxsci\/kfj061","volume":"90","author":"N Gamage","year":"2006","unstructured":"Gamage, N. et al. Human sulfotransferases and their role in chemical metabolism. Toxicol. Sci. 90, 5\u201322. https:\/\/doi.org\/10.1093\/toxsci\/kfj061 (2006).","journal-title":"Toxicol. Sci."},{"key":"88393_CR8","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1124\/dmd.30.8.944","volume":"30","author":"W Honma","year":"2002","unstructured":"Honma, W. et al. Phenol sulfotransferase, ST1A3, as the main enzyme catalyzing sulfation of troglitazone in human liver. Drug Metab. Dispos. 30, 944\u2013949. https:\/\/doi.org\/10.1124\/dmd.30.8.944 (2002).","journal-title":"Drug Metab. Dispos."},{"key":"88393_CR9","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1124\/dmd.110.036566","volume":"39","author":"HE Cubitt","year":"2011","unstructured":"Cubitt, H. E., Houston, J. B. & Galetin, A. Prediction of human drug clearance by multiple metabolic pathways: Integration of hepatic and intestinal microsomal and cytosolic data. Drug Metab. Dispos. 39, 864\u2013873. https:\/\/doi.org\/10.1124\/dmd.110.036566 (2011).","journal-title":"Drug Metab. Dispos."},{"key":"88393_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/jb\/mvv062","volume":"158","author":"A Yamamoto","year":"2015","unstructured":"Yamamoto, A. et al. Sulphation of acetaminophen by the human cytosolic sulfotransferases: A systematic analysis. J. Biochem. 158, 497\u2013504. https:\/\/doi.org\/10.1093\/jb\/mvv062 (2015).","journal-title":"J. Biochem."},{"key":"88393_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.abb.2018.04.019","volume":"648","author":"AF Bairam","year":"2018","unstructured":"Bairam, A. F. et al. Effects of human SULT1A3\/SULT1A4 genetic polymorphisms on the sulfation of acetaminophen and opioid drugs by the cytosolic sulfotransferase SULT1A3. Arch. Biochem. Biophys. 648, 44\u201352. https:\/\/doi.org\/10.1016\/j.abb.2018.04.019 (2018).","journal-title":"Arch. Biochem. Biophys."},{"key":"88393_CR12","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1124\/dmd.109.028399","volume":"37","author":"Z Riches","year":"2009","unstructured":"Riches, Z., Stanley, E. L., Bloomer, J. C. & Coughtrie, M. W. H. Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: The SULT \u201cpie\u201d. Drug Metab. Dispos. 37, 2255\u20132261. https:\/\/doi.org\/10.1124\/dmd.109.028399 (2009).","journal-title":"Drug Metab. Dispos."},{"key":"88393_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/toxsci\/kfq296","volume":"118","author":"X Yu","year":"2010","unstructured":"Yu, X. et al. Functional genetic variants in the 3\u2032-untranslated region of sulfotransferase isoform 1A1 (SULT1A1) and their effect on enzymatic activity. Toxicol. Sci. 118, 391\u2013403. https:\/\/doi.org\/10.1093\/toxsci\/kfq296 (2010).","journal-title":"Toxicol. Sci."},{"key":"88393_CR14","doi-asserted-by":"crossref","unstructured":"Yu, X., Kubota, T., Dhakal, I. et al. Copy number variation in sulfotransferase isoform 1A1 (SULT1A1) is significantly associated with enzymatic activity in Japanese subjects. Pharmgenom. Pers. Med. 6, 19\u201324 (2013)","DOI":"10.2147\/PGPM.S36579"},{"key":"88393_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/03602532.2017.1335749","volume":"49","author":"N Marto","year":"2017","unstructured":"Marto, N., Morello, J., Monteiro, E. C. & Pereira, S. A. Implications of sulfotransferase activity in interindividual variability in drug response: Clinical perspective on current knowledge. Drug Metab. Rev. 49, 357\u2013371. https:\/\/doi.org\/10.1080\/03602532.2017.1335749 (2017).","journal-title":"Drug Metab. Rev."},{"key":"88393_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/sj.tpj.6500117","volume":"2","author":"MWH Coughtrie","year":"2002","unstructured":"Coughtrie, M. W. H. Sulfation through the looking glass\u2014Recent advances in sulfotransferase research for the curious. Pharmacogenom. J. 2, 297\u2013308. https:\/\/doi.org\/10.1038\/sj.tpj.6500117 (2002).","journal-title":"Pharmacogenom. J."},{"key":"88393_CR17","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1212\/wnl.40.7.1095","volume":"40","author":"GB Steventon","year":"1990","unstructured":"Steventon, G. B. et al. Xenobiotic metabolism in Alzheimer\u2019s disease. Neurology 40, 1095\u20131098. https:\/\/doi.org\/10.1212\/wnl.40.7.1095 (1990).","journal-title":"Neurology"},{"key":"88393_CR18","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/s0006-3223(98)00337-0","volume":"46","author":"A Alberti","year":"1999","unstructured":"Alberti, A. et al. Sulphation deficit in \u201clow-functioning\u201d autistic children: A pilot study. Biol. Psychiatry 46, 420\u2013424. https:\/\/doi.org\/10.1016\/s0006-3223(98)00337-0 (1999).","journal-title":"Biol. Psychiatry"},{"key":"88393_CR19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1046\/j.1468-2982.1997.1707761.x","volume":"17","author":"Z Alam","year":"1997","unstructured":"Alam, Z. et al. Platelet sulphotransferase activity, plasma sulphate levels and sulphation capacity in patients with migraine and tension headache. Cephalalgia 17, 761\u2013764. https:\/\/doi.org\/10.1046\/j.1468-2982.1997.1707761.x (1997).","journal-title":"Cephalalgia"},{"key":"88393_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3109\/00498259009046818","volume":"20","author":"GB Steventon","year":"1990","unstructured":"Steventon, G. B. et al. Metabolism of low-dose paracetamol in patients with chronic neurological disease. Xenobiotica 20, 117\u2013122. https:\/\/doi.org\/10.3109\/00498259009046818 (1990).","journal-title":"Xenobiotica"},{"key":"88393_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3109\/00498259109039509","volume":"21","author":"H Bradley","year":"1991","unstructured":"Bradley, H., Waring, R. H., Emery, P. & Arthur, V. Metabolism of low-dose paracetamol in patients with rheumatoid arthritis. Xenobiotica 21, 689\u2013693. https:\/\/doi.org\/10.3109\/00498259109039509 (1991).","journal-title":"Xenobiotica"},{"key":"88393_CR22","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/0168-8278(95)80450-1","volume":"22","author":"MH Davies","year":"1995","unstructured":"Davies, M. H. et al. Sulphoxidation and sulphation capacity in patients with primary biliary cirrhosis. J. Hepatol. 22, 551\u2013560. https:\/\/doi.org\/10.1016\/0168-8278(95)80450-1 (1995).","journal-title":"J. Hepatol."},{"key":"88393_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3109\/03602532.2013.835621","volume":"45","author":"J Daniels","year":"2013","unstructured":"Daniels, J. & Kadlubar, S. Sulfotransferase genetic variation: From cancer risk to treatment response. Drug Metab. Rev. 45, 415\u2013422. https:\/\/doi.org\/10.3109\/03602532.2013.835621 (2013).","journal-title":"Drug Metab. Rev."},{"key":"88393_CR24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/jac\/dkt359","volume":"69","author":"AT Marinho","year":"2014","unstructured":"Marinho, A. T. et al. Differences in nevirapine biotransformation as a factor for its sex-dependent dimorphic profile of adverse drug reactions. J. Antimicrob. Chemother. 69, 476\u2013482. https:\/\/doi.org\/10.1093\/jac\/dkt359 (2014).","journal-title":"J. Antimicrob. Chemother."},{"key":"88393_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.toxlet.2016.08.009","volume":"260","author":"NM Grilo","year":"2016","unstructured":"Grilo, N. M. et al. Efavirenz biotransformation as an up-stream event of mood changes in HIV-infected patients. Toxicol. Lett. 260, 28\u201335. https:\/\/doi.org\/10.1016\/j.toxlet.2016.08.009 (2016).","journal-title":"Toxicol. Lett."},{"key":"88393_CR26","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2008.08.026","volume":"134","author":"E Holmes","year":"2008","unstructured":"Holmes, E., Wilson, I. D. & Nicholson, J. K. Metabolic phenotyping in health and disease. Cell 134, 714\u2013717. https:\/\/doi.org\/10.1016\/j.cell.2008.08.026 (2008).","journal-title":"Cell"},{"key":"88393_CR27","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/004982599238047","volume":"29","author":"JK Nicholson","year":"1999","unstructured":"Nicholson, J. K., Lindon, J. C. & Holmes, E. \u201cMetabonomics\u201d: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181\u20131189. https:\/\/doi.org\/10.1080\/004982599238047 (1999).","journal-title":"Xenobiotica"},{"key":"88393_CR28","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11708","volume":"491","author":"JK Nicholson","year":"2012","unstructured":"Nicholson, J. K. et al. Metabolic phenotyping in clinical and surgical environments. Nature 491, 384\u2013392. https:\/\/doi.org\/10.1038\/nature11708 (2012).","journal-title":"Nature"},{"key":"88393_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/00008571-200004000-00001","volume":"10","author":"DS Streetman","year":"2000","unstructured":"Streetman, D. S., Bertino, J. S. & Nafziger, A. N. Phenotyping of drug-metabolizing enzymes in adults: A review of in-vivo cytochrome P450 phenotyping probes. Pharmacogenetics 10, 187\u2013216. https:\/\/doi.org\/10.1097\/00008571-200004000-00001 (2000).","journal-title":"Pharmacogenetics"},{"key":"88393_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/bdra.20535","volume":"82","author":"AA Adjei","year":"2008","unstructured":"Adjei, A. A. et al. Interindividual variability in acetaminophen sulfation by human fetal liver: Implications for pharmacogenetic investigations of drug-induced birth defects. Birth Defects Res. Part A Clin. Mol. Teratol. 82, 155\u2013165. https:\/\/doi.org\/10.1002\/bdra.20535 (2008).","journal-title":"Birth Defects Res. Part A Clin. Mol. Teratol."},{"key":"88393_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo, S. P., Djulbegovic, B. & Hozo, I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med. Res. Methodol. 5, 13. https:\/\/doi.org\/10.1186\/1471-2288-5-13 (2005).","journal-title":"BMC Med. Res. Methodol."},{"key":"88393_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2165\/00003088-198207020-00001","volume":"7","author":"JA Forrest","year":"1982","unstructured":"Forrest, J. A., Clements, J. A. & Prescott, L. F. Clinical pharmacokinetics of paracetamol. Clin. Pharmacokinet. 7, 93\u2013107. https:\/\/doi.org\/10.2165\/00003088-198207020-00001 (1982).","journal-title":"Clin. Pharmacokinet."},{"key":"88393_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1248\/bpb.30.157","volume":"30","author":"S Shinoda","year":"2007","unstructured":"Shinoda, S. et al. Pharmacokinetics\/pharmacodynamics of acetaminophen analgesia in Japanese patients with chronic pain. Biol. Pharm. Bull. 30, 157\u2013161. https:\/\/doi.org\/10.1248\/bpb.30.157 (2007).","journal-title":"Biol. Pharm. Bull."},{"key":"88393_CR34","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604\u2013612. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006 (2009).","journal-title":"Ann. Intern. Med."},{"key":"88393_CR35","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jprot.2011.10.021","volume":"75","author":"T Pacchiarotta","year":"2012","unstructured":"Pacchiarotta, T. et al. Fibrinogen alpha chain O-glycopeptides as possible markers of urinary tract infection. J. Proteomics 75, 1067\u20131073. https:\/\/doi.org\/10.1016\/j.jprot.2011.10.021 (2012).","journal-title":"J. Proteomics"},{"key":"88393_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00204-017-2063-1","volume":"92","author":"R Gorgulho","year":"2018","unstructured":"Gorgulho, R. et al. Usefulness of zebrafish larvae to evaluate drug-induced functional and morphological renal tubular alterations. Arch. Toxicol. 92, 411\u2013423. https:\/\/doi.org\/10.1007\/s00204-017-2063-1 (2018).","journal-title":"Arch. Toxicol."},{"key":"88393_CR37","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/nbt.2377","volume":"30","author":"MC Chambers","year":"2012","unstructured":"Chambers, M. C. et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat. Biotechnol. 30, 918\u2013920. https:\/\/doi.org\/10.1038\/nbt.2377 (2012).","journal-title":"Nat. Biotechnol."},{"key":"88393_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1471-2105-11-395","volume":"11","author":"T Pluskal","year":"2010","unstructured":"Pluskal, T., Castillo, S., Villar-Briones, A. & Ore\u0161i\u010d, M. MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinform. 11, 395. https:\/\/doi.org\/10.1186\/1471-2105-11-395 (2010).","journal-title":"BMC Bioinform."},{"key":"88393_CR39","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/bioinformatics\/btk039","volume":"22","author":"M Katajamaa","year":"2006","unstructured":"Katajamaa, M., Miettinen, J. & Oresic, M. MZmine: Toolbox for processing and visualization of mass spectrometry based molecular profile data. Bioinformatics 22, 634\u2013636. https:\/\/doi.org\/10.1093\/bioinformatics\/btk039 (2006).","journal-title":"Bioinformatics"},{"key":"88393_CR40","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/0731-7085(94)00859-0","volume":"12","author":"GSN Lau","year":"1994","unstructured":"Lau, G. S. N. & Critchley, J. A. J. H. The estimation of paracetamol and its major metabolites in both plasma and urine by a single high-performance liquid chromatography assay. J. Pharm. Biomed. Anal. 12, 1563\u20131572. https:\/\/doi.org\/10.1016\/0731-7085(94)00859-0 (1994).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"88393_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/hep.23330","volume":"51","author":"RD Fannin","year":"2010","unstructured":"Fannin, R. D. et al. Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation. Hepatology 51, 227\u2013236. https:\/\/doi.org\/10.1002\/hep.23330 (2010).","journal-title":"Hepatology"},{"key":"88393_CR42","doi-asserted-by":"publisher","DOI":"10.2174\/1381612823666170207100724","author":"GA Keller","year":"2017","unstructured":"Keller, G. A., Gago, M. L. F., Diez, R. A. & Di Girolamo, G. In vivo phenotyping methods: Cytochrome P450 probes with emphasis on the cocktail approach. Curr. Pharm. Des. https:\/\/doi.org\/10.2174\/1381612823666170207100724 (2017).","journal-title":"Curr. Pharm. Des."},{"key":"88393_CR43","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev-pharmtox-010818-021909","volume":"59","author":"U Fuhr","year":"2019","unstructured":"Fuhr, U. et al. Assessment of pharmacokinetic drug-drug interactions in humans. In vivo probe substrates for drug metabolism and drug transport revisited. Annu. Rev. Pharmacol. Toxicol. 59, 507\u2013536. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010818-021909 (2019).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"88393_CR44","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/clpt.1982.211","volume":"32","author":"C Reiter","year":"1982","unstructured":"Reiter, C. & Weinshilboum, R. Platelet phenol sulfotransferase activity: Correlation with sulfate conjugation of acetaminophen. Clin. Pharmacol. Ther. 32, 612\u2013621. https:\/\/doi.org\/10.1038\/clpt.1982.211 (1982).","journal-title":"Clin. Pharmacol. Ther."},{"key":"88393_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2125.1983.tb01506.x","volume":"15","author":"SM Bonham-Carter","year":"1983","unstructured":"Bonham-Carter, S. M. et al. Human platelet phenol sulphotransferase M and P: Substrate specificities and correlation with in vivo sulphoconjugation of paracetamol and salicylamide. Br. J. Clin. Pharmacol. 15, 323\u2013330. https:\/\/doi.org\/10.1111\/j.1365-2125.1983.tb01506.x (1983).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"88393_CR46","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1515\/DMDI.1994.11.4.317","volume":"11","author":"JM Ngong","year":"1994","unstructured":"Ngong, J. M. & Waring, R. H. Circadian rhythms of paracetamol metabolism in healthy subjects; A preliminary report. Drug Metabol. Drug Interact. 11, 317\u2013330. https:\/\/doi.org\/10.1515\/DMDI.1994.11.4.317 (1994).","journal-title":"Drug Metabol. Drug Interact."},{"key":"88393_CR47","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/s0168-8278(05)80630-0","volume":"21","author":"MH Davies","year":"1994","unstructured":"Davies, M. H. et al. The adverse influence of pregnancy upon sulphation: A clue to the pathogenesis of intrahepatic cholestasis of pregnancy?. J. Hepatol. 21, 1127\u20131134. https:\/\/doi.org\/10.1016\/s0168-8278(05)80630-0 (1994).","journal-title":"J. Hepatol."},{"key":"88393_CR48","doi-asserted-by":"publisher","first-page":"14728","DOI":"10.1073\/pnas.0904489106","volume":"106","author":"TA Clayton","year":"2009","unstructured":"Clayton, T. A. et al. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc. Natl. Acad. Sci. U S A 106, 14728\u201314733. https:\/\/doi.org\/10.1073\/pnas.0904489106 (2009).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"88393_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bcp.2018.11.010","volume":"159","author":"I Cook","year":"2019","unstructured":"Cook, I., Wang, T. & Leyh, T. S. Isoform-specific therapeutic control of sulfonation in humans. Biochem. Pharmacol. 159, 25\u201331. https:\/\/doi.org\/10.1016\/j.bcp.2018.11.010 (2019).","journal-title":"Biochem. Pharmacol."},{"key":"88393_CR50","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1080\/00498250902763440","volume":"39","author":"Z Riches","year":"2009","unstructured":"Riches, Z. et al. Assessment of cryopreserved human hepatocytes as a model system to investigate sulfation and glucuronidation and to evaluate inhibitors of drug conjugation. Xenobiotica 39, 374\u2013381. https:\/\/doi.org\/10.1080\/00498250902763440 (2009).","journal-title":"Xenobiotica"},{"key":"88393_CR51","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2125.1984.tb02495.x","volume":"18","author":"J Clements","year":"1984","unstructured":"Clements, J., Critchley, J. & Prescott, L. The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man. Br. J. Clin. Pharmacol. 18, 481\u2013485. https:\/\/doi.org\/10.1111\/j.1365-2125.1984.tb02495.x (1984).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"88393_CR52","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/sj.clpt.6100050","volume":"81","author":"U Fuhr","year":"2007","unstructured":"Fuhr, U., Jetter, A. & Kirchheiner, J. Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the \u201ccocktail\u201d approach. Clin. Pharmacol. Ther. 81, 270\u2013283. https:\/\/doi.org\/10.1038\/sj.clpt.6100050 (2007).","journal-title":"Clin. Pharmacol. Ther."},{"key":"88393_CR53","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/00498254.2010.535923","volume":"41","author":"Y Alnouti","year":"2011","unstructured":"Alnouti, Y. & Klaassen, C. D. Mechanisms of gender-specific regulation of mouse sulfotransferases (Sults). Xenobiotica 41, 187\u2013197. https:\/\/doi.org\/10.3109\/00498254.2010.535923 (2011).","journal-title":"Xenobiotica"},{"key":"88393_CR54","first-page":"522","volume":"29","author":"MW Coughtrie","year":"2001","unstructured":"Coughtrie, M. W. & Johnston, L. E. Interactions between dietary chemicals and human sulfotransferases-molecular mechanisms and clinical significance. Drug Metab. Dispos. 29, 522\u2013528 (2001).","journal-title":"Drug Metab. Dispos."},{"key":"88393_CR55","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/sj.onc.1209376","volume":"25","author":"S Nowell","year":"2006","unstructured":"Nowell, S. & Falany, C. N. Pharmacogenetics of human cytosolic sulfotransferases. Oncogene 25, 1673\u20131678. https:\/\/doi.org\/10.1038\/sj.onc.1209376 (2006).","journal-title":"Oncogene"},{"key":"88393_CR56","doi-asserted-by":"publisher","unstructured":"Rohn, K.J., Cook, I.T., Leyh, T.S., et al. Potent inhibition of human sulfotransferase (SULT) 1A1 by 17alpha-ethinylestradiol (EE2): Role of 3\u2019-phosphoadenosine 5\u2019-phosphosulfate (PAPS) binding and structural rearrangements in regulating inhibition and activity. Drug Metab. Dispos. 1588\u20131595. https:\/\/doi.org\/https:\/\/doi.org\/10.1124\/dmd.112.045583 (2012)","DOI":"10.1124\/dmd.112.045583"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88393-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88393-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88393-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T07:29:28Z","timestamp":1670052568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88393-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88393"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88393-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,27]]},"assertion":[{"value":"13 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9036"}}